Value through Innovation27 July 2016

Page content

jump to main navigation jump to meta navigation

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Lay Summaries and Lay Summary Videos

  • GIOTRIF ® (afatinib) - Glioma
    Clinical Study Number 1200.38
    Study Indication Glioma
    Product GIOTRIF ® (afatinib)
    Generic Name Afatinib
    Lab Code
    Clinical Phase I
    Study Title

    Phase I, open label trial to explore safety of combining BIBW 2992 and radiotherapy with or without temozolomide in newly diagnosed GBM

    Study Document
    Lay summary 1200.38 english

New selection